Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$573.0K
TTM
Current Assets
Q1 2024
Current Liabilities
Q1 2024
Current Ratio
0.09%
Q1 2024
Total Assets
Q1 2024
Total Liabilities
Q1 2024
Book Value
-$3.795M
Q1 2024
Cash
Q1 2024
P/E
-0.1714
Sep 03, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2013 2012 2011 2010 2009 2008 2007

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $98.238 Thousand

About THC Therapeutics, Inc.

THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The firm operates in the wellness industry.

Industry: Farm Machinery & Equipment Peers: ABBOTT LABORATORIES AMERICAN BIO MEDICA CORP Bionik Laboratories Corp. ECGI Holdings, Inc. ESCALON MEDICAL CORP Wellness Center USA, Inc. Zosano Pharma Corp